Eagle Asset Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,429
Closed -$27.3K 565
2023
Q4
$27.3K Hold
10,429
﹤0.01% 557
2023
Q3
$33.4K Hold
10,429
﹤0.01% 535
2023
Q2
$52.5K Sell
10,429
-3,609
-26% -$18.3K ﹤0.01% 531
2023
Q1
$40K Buy
+14,038
New +$41K ﹤0.01% 540

Other funds holding APYX

Eagle Asset Management's APYX Position: Q1 2024 in Review

Eagle Asset Management sold out of Apyx Medical (APYX) in Q1 2024, closing a stake of 10,429 shares — an estimated $27.3K sold.

Eagle Asset Management first reported a position in APYX in Q1 2023 and held it in 4 quarters. The position peaked at $52.5K in Q2 2023. 51 funds tracked by Wall St. Rank hold APYX as of Q1 2024.

  • Eagle Asset Management reported no remaining Apyx Medical position as of Q1 2024 after selling out during the quarter.
  • Eagle Asset Management sold 10,429 Apyx Medical shares in Q1 2024, an estimated $27.3K.
  • Eagle Asset Management first reported a position in Apyx Medical in Q1 2023 and held it in 4 quarters.
  • Eagle Asset Management's Apyx Medical position peaked at $52.5K in Q2 2023.
  • 51 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2024.

Based on Eagle Asset Management's 13F filing for Q1 2024, filed 9 May 2024.